tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Stock Investors

423 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RCUS
On average, investors allocate 2.17% of their portfolios to RCUS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RCUS

2.0%
Last 7
Days
1.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RCUS, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RCUS Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,195 investors who made their portfolios public
The table shows changes in RCUS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RCUS Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.19%
-1.00%
-2.55%
833.60M
Consumer Cyclical
Bristol-Myers Squibb
3.23%
-0.90%
+1.52%
86.44B
Healthcare
DraftKings
5.78%
-1.41%
-1.97%
32.41B
Consumer Cyclical
Block
4.23%
-1.13%
-0.11%
42.02B
Technology
Applied Materials
4.57%
+0.43%
+5.13%
174.09B
Technology
Merck & Company
3.86%
-0.51%
+3.45%
318.55B
Healthcare
Riot Platforms
5.03%
-0.53%
+0.41%
3.47B
Financial
Fortinet
3.34%
-1.10%
-2.02%
44.68B
Technology
AbbVie
5.48%
-0.07%
+2.07%
304.29B
Healthcare
Airbnb
4.46%
-0.80%
+1.91%
95.31B
Consumer Cyclical
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

RCUS Investor Analysis

RCUS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
5.3%
of RCUS holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
RCUS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
47.9%
of RCUS holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
RCUS investors over 55

Over 55

10.6%
Last 30 days
Holdings Change
46.8%
of RCUS holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of RCUS stock investors
See who invests in RCUS according to age group and performance.

FAQ

How many retail Investors hold RCUS?
<0.1% of TipRanks' retail investors hold RCUS in their portfolios.
    What is RCUS Investor Sentiment?
    RCUS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RCUS in the last 7 days?
      ▼ 2.0% of TipRanks' retail investors changed their holding of RCUS in the last 7 days.
        What percentage of retail investors changed their holding of RCUS in the last 30 days?
        ▼ 1.6% of TipRanks' retail investors changed their holding of RCUS in the last 30 days.
          What is the average age of retail investors who hold RCUS?
          The average age of RCUS Holders is between 35–55.
            What other stocks have RCUS investors also bought?
            RCUS Investors also bought CHPT, BMY, DKNG, SQ, AMAT, MRK, RIOT, FTNT, ABBV, ABNB.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis